Article Text
PDFHow to do it
‘Undiagnosing’ neurological disease: how to do it, and when not to
Statistics from Altmetric.com
Footnotes
-
Funding None.
-
Competing interests None.
-
Patient consent Obtained.
-
Provenance and peer review Not commissioned; externally peer reviewed. This paper was reviewed by Andrew Chancellor, Tauranga, New Zealand.
Linked Articles
- Editors' choice
Read the full text or download the PDF:
Other content recommended for you
- Cancer in patients with motor neuron disease, multiple sclerosis and Parkinson's disease: record linkage studies
- Neurofilament light chain as a biomarker in neurological disorders
- Presymptomatic and longitudinal neuroimaging in neurodegeneration—from snapshots to motion picture: a systematic review
- ABN joint annual meeting 2009 with the Spanish Society of Neurology
- Beyond and below the cortex: the contribution of striatal dysfunction to cognition and behaviour in neurodegeneration
- Parkinson's disease: chameleons and mimics
- What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies
- Measuring network disruption in neurodegenerative diseases: New approaches using signal analysis
- Amyotrophic lateral sclerosis is not linked to multiple sclerosis in a population based study
- Impact of DaTscan SPECT imaging on clinical management, diagnosis, confidence of diagnosis, quality of life, health resource use and safety in patients with clinically uncertain parkinsonian syndromes: a prospective 1-year follow-up of an open-label controlled study